- Home
- SNGX vs YGMZ Comparison
SNGX vs YGMZ Comparison
Compare SNGX & YGMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNGX
- YGMZ
- Stock Information
- Founded
- SNGX 1987
- YGMZ 2002
- Country
- SNGX United States
- YGMZ China
- Employees
- SNGX N/A
- YGMZ 26
- Industry
- SNGX Biotechnology: Pharmaceutical Preparations
- YGMZ Transportation Services
- Sector
- SNGX Health Care
- YGMZ Consumer Discretionary
- Exchange
- SNGX Nasdaq
- YGMZ Nasdaq
- Market Cap
- SNGX 10.1M
- YGMZ 57.6M
- IPO Year
- SNGX 1987
- YGMZ 2020
- Fundamental
- Price
- SNGX $2.79
- YGMZ $0.75
- Analyst Decision
- SNGX Strong Buy
- YGMZ
- Analyst Count
- SNGX 1
- YGMZ 0
- Target Price
- SNGX $6.00
- YGMZ N/A
- AVG Volume (30 Days)
- SNGX 871.1K
- YGMZ 155.9K
- Earning Date
- SNGX 11-07-2025
- YGMZ 01-01-0001
- Dividend Yield
- SNGX N/A
- YGMZ N/A
- EPS Growth
- SNGX N/A
- YGMZ N/A
- EPS
- SNGX N/A
- YGMZ N/A
- Revenue
- SNGX N/A
- YGMZ $40,429,750.00
- Revenue This Year
- SNGX N/A
- YGMZ N/A
- Revenue Next Year
- SNGX N/A
- YGMZ N/A
- P/E Ratio
- SNGX N/A
- YGMZ N/A
- Revenue Growth
- SNGX N/A
- YGMZ N/A
- 52 Week Low
- SNGX $1.09
- YGMZ $0.63
- 52 Week High
- SNGX $6.23
- YGMZ $1.77
- Technical
- Relative Strength Index (RSI)
- SNGX 49.04
- YGMZ 44.75
- Support Level
- SNGX $2.58
- YGMZ $0.73
- Resistance Level
- SNGX $2.98
- YGMZ $0.85
- Average True Range (ATR)
- SNGX 0.20
- YGMZ 0.14
- MACD
- SNGX -0.08
- YGMZ -0.01
- Stochastic Oscillator
- SNGX 32.81
- YGMZ 15.29
About SNGX Soligenix Inc.
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).
About YGMZ MingZhu Logistics Holdings Limited
MingZhu Logistics Holdings Ltd is a Holding company. Its business activities include trucking services and car owner services. The segments of the company are the trucking business, car owner services business, and liquor distribution business.